SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is experiencing significant selling pressure amid community speculation regarding the company's ability to meet upcoming nuclear criticality deadlines and recurring concerns over share dilution. While some investors view the current price action as a base-building accumulation phase ahead of potential long-term infrastructure contracts for AI data centers, others are aggressively shorting the stock, citing a lack of current revenue and missed project timelines.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike shares are facing selling pressure as investors lock in profits following a significant rally, compounded by short-term volatility surrounding its recent 4-for-1 stock split. The community remains focused on the company's long-term leadership in AI-driven cybersecurity and platform consolidation, with many investors actively debating whether the current pullback offers a buying opportunity or a necessary correction from a premium valuation.

OpenAI

OpenAI is trending as investors react to reports of a potential IPO delay until 2027 amid concerns over the company's heavy capital spending and profitability challenges. Meanwhile, community discussion is heavily focused on the company's recent strategic shifts, including a proposal to offer the U.S. government an equity stake and the intensified competitive pressure from Anthropic.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following the announcement of a massive multi-billion dollar, multi-year custom chip and wireless technology agreement with Broadcom to boost U.S.-based manufacturing. While the community is actively debating the stock's valuation, price action, and potential for a breakout toward all-time highs, many traders are closely focused on institutional positioning and options flow as a primary driver of the current momentum.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is trending as investors weigh strong AI-driven growth and a raised revenue forecast against technical volatility and institutional selling pressure. The community is actively debating the stock's short-term path, with some traders monitoring key technical support levels and potential gap-fills, while long-term investors remain focused on the company's expanding role in generative AI data engineering.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending as investors react to strong earnings and revenue that outperformed expectations, even as the company navigates ongoing fuel cost pressures and cautious forward guidance. The community is actively debating the stock's resilience and long-term upside potential, specifically analyzing how its premium service strategy and diversified revenue streams will offset broader macroeconomic headwinds.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing significant market interest and volatility ahead of the PDUFA date for the Alzheimer's disease agitation indication of Auvelity, with investors debating the potential for an FDA approval catalyst. The community is heavily focused on the company's aggressive sales force expansion, the strategic importance of the Alzheimer's market, and ongoing speculation regarding potential ex-U.S. licensing deals or future buyout prospects.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is experiencing significant volatility as investors debate the impact of stagnant OTC trading volume and ongoing management restructuring, while the community remains sharply divided over the potential for a future relisting. While some bulls are actively buying dips, citing the company's aggressive expansion and recent analyst initiation, many others are expressing frustration over the persistent downward price pressure and lack of clear communication regarding the share buyback program.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is rallying as investors digest positive analyst upgrades and reports of new AI-driven demand, while the broader community debates if the stock's recent rebound signals a return to all-time highs. Bullish sentiment is heavily fueled by the record-breaking IPO of key partner SK Hynix, which has reinforced confidence in the long-term strength of the AI infrastructure supply chain.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility and bearish sentiment driven by debt concerns, a credit rating downgrade, and broader market skepticism regarding the sustainability of AI infrastructure spending. While some traders view the stock as deeply oversold and are positioned for a potential short-term bounce or technical recovery, others remain cautious, highlighting the stock's struggle to maintain gains and its ongoing susceptibility to algorithmic selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular session.
Forte Biosciences (NASDAQ:FBRX) shares moved upwards by 18.39% to $43.45. The market value of theirread more...

TRAX Stock Hits All-Time High — What's Driving The Super Rally?

Equity

According to TheFly, HC Wainwright raised its price target on First Tracks to $44 from $30 while maintaining a ‘Buy’ rating.


FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data

Forte Biosciences stock soars after early-stage data show FB102 significantly improves facial depigmentation in vitiligo with a favorable safety profile.

FBRX Stock On Track For Biggest Single-Day Gains In 20 Months – What’s Behind The Super Rally?

Forte Biosciences announced results from its early-stage study for its investigational drug to treat an autoimmune skin condition.

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million.
Forte Biosciences (NASDAQ:FBRX) stock roseread more...

Forte Biosciences Skin Pigmentation Disorder Drug Shows Strong Efficacy, Safety In Early Study

Forte Biosciences reported positive Phase 1b vitiligo data, with FB102 showing significant facial repigmentation and favorable safety.read more...

FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive results from the FB102 double-blind placebo-controlled phase 1b study in vitiligo: FB102 achieved 29.6% mean FVASI...

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing...

Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its first quarter 2026...

Wall Street Zen Upgrades Forte Biosciences (NASDAQ:FBRX) to "Sell"

Wall Street Zen upgraded shares of Forte Biosciences from a 'strong sell' rating to a 'sell' rating in a research note on Saturday...

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Bearish Sentiment

Yes, I'm a buyer

Just watching

No, I'm not interested

The highly anticipated ADR listing of SK Hynix ($SKHYV) goes live today. Are you a buyer of the stock? Drop your long-term thesis in the comments.

SK Hynix ($SKHYV) listing day is upon us - are you a buyer? 
 
Drop a comment with your strategy.

Stocktwits

SK Hynix Inc - ADR

SK Hynix ($SKHY) listing day is upon us - are you a buyer? 
 
Drop a comment with your strategy.

Stocktwits Polls

Traders are actively speculating that a shelf offering is imminent to capitalize on the rapid stock price surge.

Investors are debating if positive Phase 1b clinical data on the FB102 drug warrants the triple-digit percentage gains.

Intense friction continues between bulls aiming for higher price targets and bears aggressively shorting the current rally.

Technical traders are pointing to suspicious price action as a potential double-top pattern indicating a likely reversal.

Current Price	$43.92
Prev Close	$36.70
Open	$37.94
Dividend Yield	0.00%
50-Day Moving Average	$21.48
Beta	0.65
Avg. Volume	416,067.32
PE Ratio	-7.19

52-Week High	$37.58
52-Week Low	$9.10
Market Capitalization	$751.57M
EPS (Annual)	-$4.71
Price to Book	12.13
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

FBRXForte Biosciences Inc

Latest FBRX News